- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02750241
Pink Warrior-Support Group Toolkit for Breast Cancer Survivors
Breast cancer survivors, from diagnosis until the end of life, go through many transitions. One major transition is the significant decrease of physical activity immediately after diagnosis. Despite the known benefits of physical activity-speeding recovery time and reduced cancer recurrence risk-only 1 in 3 survivors met physical activity recommendations of 150 minutes of moderate-intensity activity per week. Physical activity interventions have shown effectiveness in helping breast cancer survivors increase physical activity during treatment, but limited evidence-based physical activity interventions have been incorporated into the clinic and community. To address this limitation, the investigators are partnering with the UTMB breast cancer support group to conduct a 12-week physical activity intervention, Pink Warrior.
The goal of this study is to compare an intervention that uses active games versus an intervention uses pedometer to encourage physical activity such as walking within breast cancer survivors in active cancer treatment. The study will include breast cancer survivor between the ages of 18 - 70 whom currently gets less than 150 minutes of planned physical activity per week and received a breast cancer diagnosis within 0 to 6 months. Participants will be randomized to participate in the support group using the active video game-based physical activity intervention (Wii and Xbox active games) or to participate in the existing UTMB breast cancer support group with pedometers (Digi-Walker CW-700/701). The investigators hypothesize that by engaging in active video gaming, breast cancer survivors will be motivated to initiate and maintain physical activity during treatment. This will ultimately increase functional capacity and prevent functional disability in breast cancer survivors.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Increasing and maintaining physical activity among female breast cancer (BC) survivors during treatment remains an unresolved problem in BC survivorship care. BC survivors, from diagnosis until the end of life, go through many transitions. One major transition is the significant decline of physical activity immediately after diagnosis. Despite the known benefits of physical activity-speeding recovery time and reduced cancer recurrence risk-less than 30% of survivors met physical activity recommendations. Physical activity interventions have shown effectiveness in helping BC survivors increase activity during treatment, but limited evidence-based activity interventions have been disseminated into the clinic and community. To address this limitation, we are partnering with the UTMB breast cancer support group to conduct a 12-week physical activity intervention, Pink Warrior, which will investigate the feasibility of implementing active video game-based physical activity intervention among BC survivors undergoing treatment within the support group setting. Participants (N = 60) will be randomized to participate in the support group using the active video game-based physical activity intervention or to participate in the existing UTMB breast cancer support group with pedometers. Our specific aims are:
Aim 1: Evaluate the feasibility and acceptability of active video game-based physical activity intervention among BC survivors undergoing treatment within the support group setting. Measures of feasibility will include weekly attendance records, number of completed home-based worksheets, number of participants completing the program activities, technological issues, and adverse events.
Aim 2: Compare the support group using the active video game-based physical activity intervention to the existing UTMB breast cancer support group with pedometer. Primary outcomes will be changes in physical activity. Secondary outcomes will be changes in physical function, dietary pattern, and quality of life.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Texas
-
Galveston, Texas, United States, 77550
- The University of Texas Medical Branch
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Provide informed consent
- Diagnosed with primary female breast cancer within 0 to 6 months period of time
- English-speaking between the ages of 18 and 70
- Able to read and write in English
- Obtained approval from oncologists for the participant to be involved in the physical activity based support group
- Able to travel to the UTMB Breast Health Center
- Able to move arms and legs as well as ambulate
- Able to see TV screen from a distance of 2 to 4 feet
Exclusion Criteria:
- Being pregnant
- Dementia
- Currently engage in ≥150 minutes of planned moderate physical activity per week for the prior week
- Are involved in another physical activity intervention
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Active video game-based intervention
This arm will receive the active video game-based intervention, which will include attending 12 weekly group sessions at the UTMB Breast Health Clinic, participate in self-paced home session, and monitor daily, weekly, and monthly steps using Wii Fit Meter.
All participant will be provided a water bottle and a tote bag as a token of appreciation for participation.
|
|
|
Active Comparator: Pedometer
This arm will receive the pedometer intervention, which will include attending 3 monthly UTMB Breast Cancer Support Group sessions, and monitor daily, weekly, and monthly steps using a pedometer (Digit-Walker CW-700/701).
All participant will be provided a water bottle and a tote bag as a token of appreciation for participation.
|
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in physical activity steps per day as measured by an Actigraph monitor
Time Frame: Change in steps per day from baseline to 14 weeks
|
Change in steps per day between 14 weeks and baseline as measured by an Actigraph monitor
|
Change in steps per day from baseline to 14 weeks
|
|
Change in physical activity minutes as measured by an Actigraph monitor
Time Frame: Change in physical activity minutes from baseline to 14 weeks
|
Change in physical activity minutes between 14 weeks and baseline as measured by an Actigraph monitor
|
Change in physical activity minutes from baseline to 14 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in physical function as measured by the Short Physical Performance Battery (SPPB)
Time Frame: Change in physical function from baseline and 14 weeks
|
The SPPB consists of six components: repeated chair sit and stands, balance test, semi-tandem stand, tandem stand, side-by-side stand, and eight feet walk
|
Change in physical function from baseline and 14 weeks
|
|
Change in dietary pattern as measured by the Dietary Screener Questionnaire
Time Frame: Change in dietary pattern from baseline and 14 weeks
|
Change in dietary pattern from baseline and 14 weeks] [Safety Issue: No] The Dietary Screener Questionnaire used in the National Health and Nutrition Examination Survey 2009-10.
The screener captures frequency of fruits, vegetables, dairy/calcium, added sugar, whole grains/fiber, red meat, and processed meat consumption within the past 30 days
|
Change in dietary pattern from baseline and 14 weeks
|
|
Change in quality of life as measured by the Functional Assessment of Cancer Therapy-Breast measure
Time Frame: Change in quality of life from baseline and 14 weeks
|
Changes in physical, social, emotional, functional, and additional well-being between 14 weeks and baseline as measured by FACT-B
|
Change in quality of life from baseline and 14 weeks
|
|
Change in hand grip strength as measured by hand dynamometer
Time Frame: Change in hand grip strength from baseline to 14 weeks
|
Hand dynamometer estimates the muscle strength generated from flexor muscles of the hand and the forearm
|
Change in hand grip strength from baseline to 14 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in weight
Time Frame: Change in weight from baseline to 14 weeks
|
Change in body weight between 14 weeks and baseline as measured by a weight scale in the clinic
|
Change in weight from baseline to 14 weeks
|
|
Change in waist circumference
Time Frame: Change in waist circumference from baseline to 14 weeks
|
Change in waist circumference between 14 weeks and baseline as measured by Seca-203
|
Change in waist circumference from baseline to 14 weeks
|
|
Change in physical activity minutes, measured by the Community Healthy Activities Model Program for Seniors
Time Frame: Change in physical activity minutes from baseline to 14 weeks
|
Self-reported physical activity questionnaire
|
Change in physical activity minutes from baseline to 14 weeks
|
|
Change in physical function, measured by PROMIS measure specific to cancer survivors
Time Frame: Change in physical function from baseline to 14 weeks
|
Changes in overall self-reported physical functions between 14 weeks and baseline as measured by PROMIS-Ca Bank v1.1-Physical
Function
|
Change in physical function from baseline to 14 weeks
|
|
Change in fatigue, measured by PROMIS measure specific to cancer survivors
Time Frame: Change in fatigue from baseline to 14 weeks
|
Changes in overall self-reported fatigue level between 14 weeks and baseline as measured by PROMIS-Ca Bank v1.1-Fatigue
|
Change in fatigue from baseline to 14 weeks
|
|
Change in exercise motivation, measured by autonomous motivation specific to physical activity
Time Frame: Change in motivation from baseline to 14 weeks
|
Behavioral regulation in Exercise Questionnaire-2 will be used
|
Change in motivation from baseline to 14 weeks
|
|
Change in psychological feelings, measured by Psychological Need Satisfaction in Exercise Scale
Time Frame: Change in psychological feelings from baseline to 14 weeks
|
Sub-scales included perceived competence, perceived autonomy, and perceived relatedness
|
Change in psychological feelings from baseline to 14 weeks
|
|
Change in self-regulation, measured by Rovinak et al. scale
Time Frame: Change in self-regulation from baseline to 14 weeks
|
Sub-scales include exercise goals and exercise plans
|
Change in self-regulation from baseline to 14 weeks
|
|
Feasibility-Adherence
Time Frame: 14 weeks
|
Adherence will be measured by number of participants who completed at least 80% of the program activities.
|
14 weeks
|
|
Feasibility-Attrition
Time Frame: 14 weeks
|
Attrition will be measured by percentage of people who dropped out of the intervention program.
|
14 weeks
|
|
Feasibility-Technological Issues
Time Frame: 14 weeks
|
Technological issues will be measured by counting number of occurrence
|
14 weeks
|
|
Feasibility-Adverse Events
Time Frame: 14 weeks
|
Adverse events will be measured by counting number of occurrence
|
14 weeks
|
|
Acceptability
Time Frame: 14 weeks
|
Participant acceptability and satisfaction will be assessed by a questionnaire with 5-point scale responses
|
14 weeks
|
Collaborators and Investigators
Investigators
- Principal Investigator: Maria Swartz, PhD, MPH, The University of Texas Medical Branch
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 16-0040
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Cancer
-
Baylor Breast Care CenterRecruitingBreast Cancer | Breast Neoplasm | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | HER2-positive Breast Cancer | Breast Cancer Stage II | Breast Cancer Female | Breast Cancer Stage III | Estrogen Receptor-positive Breast Cancer | Hormone Receptor-positive Breast Cancer | Breast Cancer InvasiveUnited States
-
Innocrin PharmaceuticalCompletedBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Male Breast Cancer | ER+ Breast Cancer | Cancer of the BreastUnited States
-
Northwestern UniversityEisai Inc.UnknownMale Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative...United States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedInflammatory Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIB Breast Cancer | Estrogen Receptor-negative Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative Breast Cancer | Progesterone Receptor-positive Breast CancerUnited States
-
University of Colorado, DenverCompletedStage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast CancerUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyActive, not recruitingStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
National Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerCanada
-
Mayo ClinicMarker Therapeutics, Inc.CompletedHER2-positive Breast Cancer | Male Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast CancerUnited States
-
University of Central FloridaFlorida Department of HealthRecruitingBreast Cancer | Breast Cancer Female | Breast Cancer Diagnosis | Breast Cancer Survivors | Breast Cancer Detection | Breast Cancer AwarenessUnited States
Clinical Trials on Active video game-based intervention
-
Uludag UniversityNot yet recruitingPain Management | Breathing Exercise | Non-Pharmacological Interventions | Venipuncture Pain
-
University of Santiago de CompostelaEuropean Regional Development Fund; Center for Industrial Technological Development...Completed
-
Brigham Young UniversityCompleted
-
Bard CollegeUniversity of Texas at AustinCompleted
-
Taipei Medical University HospitalCompleted
-
Professor Fernando Figueira Integral Medicine InstituteUniversidade Estadual da ParaibaCompletedPhysical Activity | Overweight and Obesity | Cardiovascular Risk FactorBrazil
-
Massachusetts Eye and Ear InfirmaryCompleted
-
Federal University of ParaíbaCompleted
-
Baylor College of MedicineNational Cancer Institute (NCI)CompletedPhysical Inactivity in ChildrenUnited States
-
Medipol UniversityNot yet recruiting